Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11413 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1725 Views
-
Last post by NHE
-
- 0 Replies
- 1385 Views
-
Last post by NHE
-
- 4 Replies
- 1504 Views
-
Last post by NHE
-
- 0 Replies
- 1214 Views
-
Last post by NHE
-
- 0 Replies
- 1515 Views
-
Last post by NHE
-
- 0 Replies
- 1971 Views
-
Last post by frodo
-
- 0 Replies
- 2012 Views
-
Last post by NHE
-
- 0 Replies
- 1604 Views
-
Last post by NHE